We conducted a retrospective case–control analysis at the Department of Oncology and Lung Cancer Center of China‐Japan Friendship Hospital to investigate the impact of BMI and apoB‐containing lipoproteins on the clinical outcome of chemotherapy and ICIs combination regimens in NSCLC patients. The gene discussed is APOB; the disease is non-small cell lung carcinoma.